NFKB1 and neoplasm: The functional role of NF-κB activation in GBMs is not yet clear and its aberrant activation may not be a cause but rather a consequence of the tumor microenvironment that is characterized by NF-κB activating conditions such as dysregulated cytokine expression and hypoxia.49